ArticleJournal of multidisciplinary healthcare2025
The Skin: A Critical Window into Chronic Kidney Disease and a Call for Collaborative Care.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose/Objective: Chronic kidney disease (CKD), a complex and progressive condition, affects multiple organ systems, including the skin, where manifestations are common yet often underrecognized. This commentary aims to highlight these dermatologic signs as not only indicators of disease severity but also as opportunities for earlier intervention, improved patient comfort, and multidisciplinary collaboration. By examining the clinical relevance, educational importance, and research potential of CKD, we aim to promote a more comprehensive and proactive approach to its management. Materials/Methods – Literature Review: This expert commentary emphasizes the clinical significance of skin manifestations in chronic kidney disease and advocates for a comprehensive, multidisciplinary approach grounded in research, education, and patient-centered care. Findings/Results: Management of CKD should be integrated into standard nephrology care, with particular focus on symptoms such as pruritus, xerosis, and calciphylaxis, which not only cause discomfort but may also signal treatment deficiencies. Interdisciplinary collaboration among dermatologists, somatologists, and nephrologists is crucial to ensure timely diagnosis and comprehensive care. Additionally, educating patients about the potential skin-related complications of renal disease and encouraging them to report symptoms early can improve treatment adherence and lead to better outcomes. Conclusion and Recommendations: Cutaneous signs in CKD patients need more clinical focus, as they often signal early systemic problems and greatly affect quality of life. A comprehensive, patient-focused approach based on research, education, and policy change will be key to improving outcomes and enhancing the well-being of those with kidney disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.